Wook Kim
Director of Finance/CFO chez HLB GLOBAL CO., LTD.
Profil
Wook Kim is currently the Chief Financial Officer & Director at HLB GLOBAL Co., Ltd.
and also holds a Director position at HLB Co., Ltd.
He previously worked as a Director at Elevar Therapeutics, Inc. Mr. Kim completed his undergraduate degree at Korea University.
Postes actifs de Wook Kim
| Sociétés | Poste | Début |
|---|---|---|
| HLB CO., LTD. | Director/Board Member | - |
| HLB GLOBAL CO., LTD. | Director of Finance/CFO | 01/08/2018 |
Anciens postes connus de Wook Kim
| Sociétés | Poste | Fin |
|---|---|---|
Elevar Therapeutics, Inc.
 Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Director/Board Member | - |
Formation de Wook Kim
| Korea University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| HLB GLOBAL CO., LTD. | Energy Minerals |
| HLB CO., LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Elevar Therapeutics, Inc.
Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Health Technology |
